Serum-free manufacturing of mesenchymal stem cell tissue rings using human-induced pluripotent stem cells

Tackla S. Winston, Kantaphon Suddhapas, Chenyan Wang, Rafael Ramos, Pranav Soman, Zhen Ma

Research output: Contribution to journalArticle

Abstract

Combination of stem cell technology and 3D biofabrication approaches provides physiological similarity to in vivo tissues and the capability of repairing and regenerating damaged human tissues. Mesenchymal stem cells (MSCs) have been widely used for regenerative medicine applications because of their immunosuppressive properties and multipotent potentials. To obtain large amount of high-quality MSCs without patient donation and invasive procedures, we differentiated MSCs from human-induced pluripotent stem cells (hiPSC-MSCs) using serum-free E6 media supplemented with only one growth factor (bFGF) and two small molecules (SB431542 and CHIR99021). The differentiated cells showed a high expression of common MSC-specific surface markers (CD90, CD73, CD105, CD106, CD146, and CD166) and a high potency for osteogenic and chondrogenic differentiation. With these cells, we have been able to manufacture MSC tissue rings with high consistency and robustness in pluronic-coated reusable PDMS devices. The MSC tissue rings were characterized based on inner diameter and outer ring diameter and observed cell-type-dependent tissue contraction induced by cell-matrix interaction. Our approach of simplified hiPSC-MSC differentiation, modular fabrication procedure, and serum-free culture conditions has a great potential for scalable manufacturing of MSC tissue rings for different regenerative medicine applications.

Original languageEnglish (US)
Article number5654324
JournalStem Cells International
Volume2019
DOIs
StatePublished - Jan 1 2019

Fingerprint

Induced Pluripotent Stem Cells
Mesenchymal Stromal Cells
Serum
Regenerative Medicine
Poloxamer
Serum-Free Culture Media
Immunosuppressive Agents
Cell Communication
Cell Differentiation
Intercellular Signaling Peptides and Proteins
Stem Cells
Technology
Equipment and Supplies

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Serum-free manufacturing of mesenchymal stem cell tissue rings using human-induced pluripotent stem cells. / Winston, Tackla S.; Suddhapas, Kantaphon; Wang, Chenyan; Ramos, Rafael; Soman, Pranav; Ma, Zhen.

In: Stem Cells International, Vol. 2019, 5654324, 01.01.2019.

Research output: Contribution to journalArticle

@article{903b8c7ce47b4941aba3bcc7ad9ee0b7,
title = "Serum-free manufacturing of mesenchymal stem cell tissue rings using human-induced pluripotent stem cells",
abstract = "Combination of stem cell technology and 3D biofabrication approaches provides physiological similarity to in vivo tissues and the capability of repairing and regenerating damaged human tissues. Mesenchymal stem cells (MSCs) have been widely used for regenerative medicine applications because of their immunosuppressive properties and multipotent potentials. To obtain large amount of high-quality MSCs without patient donation and invasive procedures, we differentiated MSCs from human-induced pluripotent stem cells (hiPSC-MSCs) using serum-free E6 media supplemented with only one growth factor (bFGF) and two small molecules (SB431542 and CHIR99021). The differentiated cells showed a high expression of common MSC-specific surface markers (CD90, CD73, CD105, CD106, CD146, and CD166) and a high potency for osteogenic and chondrogenic differentiation. With these cells, we have been able to manufacture MSC tissue rings with high consistency and robustness in pluronic-coated reusable PDMS devices. The MSC tissue rings were characterized based on inner diameter and outer ring diameter and observed cell-type-dependent tissue contraction induced by cell-matrix interaction. Our approach of simplified hiPSC-MSC differentiation, modular fabrication procedure, and serum-free culture conditions has a great potential for scalable manufacturing of MSC tissue rings for different regenerative medicine applications.",
author = "Winston, {Tackla S.} and Kantaphon Suddhapas and Chenyan Wang and Rafael Ramos and Pranav Soman and Zhen Ma",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/5654324",
language = "English (US)",
volume = "2019",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Serum-free manufacturing of mesenchymal stem cell tissue rings using human-induced pluripotent stem cells

AU - Winston, Tackla S.

AU - Suddhapas, Kantaphon

AU - Wang, Chenyan

AU - Ramos, Rafael

AU - Soman, Pranav

AU - Ma, Zhen

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Combination of stem cell technology and 3D biofabrication approaches provides physiological similarity to in vivo tissues and the capability of repairing and regenerating damaged human tissues. Mesenchymal stem cells (MSCs) have been widely used for regenerative medicine applications because of their immunosuppressive properties and multipotent potentials. To obtain large amount of high-quality MSCs without patient donation and invasive procedures, we differentiated MSCs from human-induced pluripotent stem cells (hiPSC-MSCs) using serum-free E6 media supplemented with only one growth factor (bFGF) and two small molecules (SB431542 and CHIR99021). The differentiated cells showed a high expression of common MSC-specific surface markers (CD90, CD73, CD105, CD106, CD146, and CD166) and a high potency for osteogenic and chondrogenic differentiation. With these cells, we have been able to manufacture MSC tissue rings with high consistency and robustness in pluronic-coated reusable PDMS devices. The MSC tissue rings were characterized based on inner diameter and outer ring diameter and observed cell-type-dependent tissue contraction induced by cell-matrix interaction. Our approach of simplified hiPSC-MSC differentiation, modular fabrication procedure, and serum-free culture conditions has a great potential for scalable manufacturing of MSC tissue rings for different regenerative medicine applications.

AB - Combination of stem cell technology and 3D biofabrication approaches provides physiological similarity to in vivo tissues and the capability of repairing and regenerating damaged human tissues. Mesenchymal stem cells (MSCs) have been widely used for regenerative medicine applications because of their immunosuppressive properties and multipotent potentials. To obtain large amount of high-quality MSCs without patient donation and invasive procedures, we differentiated MSCs from human-induced pluripotent stem cells (hiPSC-MSCs) using serum-free E6 media supplemented with only one growth factor (bFGF) and two small molecules (SB431542 and CHIR99021). The differentiated cells showed a high expression of common MSC-specific surface markers (CD90, CD73, CD105, CD106, CD146, and CD166) and a high potency for osteogenic and chondrogenic differentiation. With these cells, we have been able to manufacture MSC tissue rings with high consistency and robustness in pluronic-coated reusable PDMS devices. The MSC tissue rings were characterized based on inner diameter and outer ring diameter and observed cell-type-dependent tissue contraction induced by cell-matrix interaction. Our approach of simplified hiPSC-MSC differentiation, modular fabrication procedure, and serum-free culture conditions has a great potential for scalable manufacturing of MSC tissue rings for different regenerative medicine applications.

UR - http://www.scopus.com/inward/record.url?scp=85065814869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065814869&partnerID=8YFLogxK

U2 - 10.1155/2019/5654324

DO - 10.1155/2019/5654324

M3 - Article

VL - 2019

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 5654324

ER -